Linezolid-associated serotonin syndrome after concomitant treatment with citalopram and mirtazepine in a critically ill bone marrow transplant recipient

Journal of Intensive Care Medicine

Volumn 20, Issue 6, 2005, Pages 303-305

  DeBellis, Ronald J ^a,b,c   Schaefer, Oren P ^b   Liquori, Michelina ^a   Volturo, Gregory A ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Antibiotic; Antidepressant; Citalopram; Linezolid; Mirtazepine; Serotonin syndrome; SSRI

Indexed keywords

ACICLOVIR; CEFTAZIDIME; CITALOPRAM; CYCLOSPORIN; DEXAMETHASONE; ESOMEPRAZOLE; LINEZOLID; MIRTAZAPINE; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; ASPIRATION PNEUMONIA; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CASE REPORT; CRITICAL ILLNESS; DIURETIC THERAPY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; PRIORITY JOURNAL; SEROTONIN SYNDROME; URINE CULTURE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 30944450782     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066605280825     Document Type: Article

References (12)

1. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138:135-142.
2. Swaney SM, Aoki H, Ganoza MC, et al: The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother. 1998;42:3251-3255.
3. Brickner SJ. Oxazolidinone antibacterial agents. Current Pharmaceutical Design. 1996;2:175-194.
4. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol. 1997;17:208-221.
5. Schatzberg AF, Haddad P, Kaplan EM, et al. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. J Clin Psychiatry. 1997;58(suppl 7):5-10.
6. McEvoy GK, Miller J, Snow EK, et al. Mirtazepine. In: AHFS Drug Information. Bethesda, Md: American Society of Health System Pharmacists; 2004:2268-2269.
7. Ubogu EE, Katirji B. Mirtazepine-induced serotonin syndrome. Clin Neuropharmacology. 2003;26:54-57.
8. Naranjo CA, Busto U, Sellers EM, et al. A method of estimating the probability of adverse reactions. Clin Pharmacol Ther. 1981;30:240.
9. Lavery S, Himabindu R, McDaniel W, Pushkin Y. Linezolid and serotonin syndrome. Psychosomatics. 2001;42:432-434.
10. Wigen CL, Goetz MB. Serotonin syndrome and linezolid. Clin Infect Dis. 2002;34:1651-1652.
11. Bernard L, Stern R, Lew D, Hottmeyer P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Inf Dis. 2003;36:1197.
12. Martin TG. Review: serotonin syndrome. Ann Emerg Med. 1996;28:520-526.